Monday May 29th 2017

Management of psoriasis vulgaris and multiple sclerosis with fumaric acid

To the Editor: Psoriasis vulgaris has not only been associated with several comorbidities like metabolic syndrome and cardiovascular disease, but also with neurologic disorders like multiple sclerosis (MS). New-onset psoriatic lesions and exacerbations have been described after treatment with biologics for MS, mainly interferon-beta (INF-β) as well as with other biologics such as natalizumab. INF-β is the first-line treatment for clinically isolated syndrome with the high risk for MS development or for relapsing-remitting multiple sclerosis (RR-MS). Fumaric acids have been a well-established therapy for psoriasis vulgaris, mainly in Germany under the trade name Fumaderm–a mixture of dimethyl fumarate (DMF) and 3 salts of ethyl hydrogen fumarate, with DMF considered to be the active ing…

MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.

More:  

Management of psoriasis vulgaris and multiple sclerosis with fumaric acid

Leave a Comment

More from category

New sleep system helps profoundly disabled 5-year-old boy with complex care needs to get full night’s sleep
New sleep system helps profoundly disabled 5-year-old boy with complex care needs to get full night’s sleep

A 5-year-old boy, who is profoundly disabled and has complex needs, has been given his first full night’s sleep [Read More]

Revisions Underway to McDonald Criteria on MS Diagnosis Revisions Underway to McDonald Criteria on MS Diagnosis
Revisions Underway to McDonald Criteria on MS Diagnosis Revisions Underway to McDonald Criteria on MS Diagnosis

An expert panel is tackling the first revision to the multiple sclerosis diagnostic criteria in 7 years. Among proposed [Read More]

Connecticut State Budget Call to Action
Connecticut State Budget Call to Action

/About-the-Society/News/Connecticut-State-Budget-Call-to-Action [Read More]

A Surge of New Drug Data in Multiple Sclerosis A Surge of New Drug Data in Multiple Sclerosis
A Surge of New Drug Data in Multiple Sclerosis A Surge of New Drug Data in Multiple Sclerosis

Medscape sits down with two neurologists to discuss advances in multiple sclerosis as presented at this year's American [Read More]

Progress on Bills to Address Step Therapy
Progress on Bills to Address Step Therapy

/About-the-Society/News/Progress-on-Bills-to-Address-Step-Therapy [Read More]